Health Catalyst Inc. (HCAT) - Company Value to Net Income

Health Catalyst, Inc. (HCAT) is developing a DOS-based software environment for clinical data analysis, creating a high level of hospital dependency on its tools. The company generates revenue from cloud-based AI services that help medical centers reduce expenses. The current metric stands at -0.60. This chart from GURU.Markets confirms the impact of growing annual recurring revenue (ARR) on the share price, despite prolonged deal cycles.

When constructing a long-term portfolio, fundamental screening requires strict control over the market value of assets. This ratio correlates the total market capitalization of Health Catalyst, Inc. (HCAT) with its net income, determining the price per unit of earnings. For a healthcare IT platform, this metric is critical due to the volatility of hospital budgets and prolonged sales cycles. By analyzing the P/E ratio dynamics, an investor can promptly detect an overvaluation of the stock.